[Calcium, phosphorus, hydroxyproline and nitrogen in inflammatory joint diseases]

Area of Science:

• Biochemistry
• Rheumatology
• Bone Metabolism

Context:

• Investigates mineral and hydroxyproline elimination in inflammatory joint diseases.
• Compares 127 patients with inflammatory joint diseases to 18 healthy controls.
• Includes patients with rheumatoid arthritis (RA), ankylosing spondylitis (ASp), and postinfectious arthritis (PA).

Purpose:

• To analyze the elimination patterns of calcium, phosphorus, hydroxyproline, and nitrogen in patients with inflammatory joint diseases.
• To compare these elimination patterns with those of healthy controls.
• To explore the relationship between these markers and specific joint diseases and patient demographics.

Summary:

• Postinfectious arthritis (PA) shows elevated elimination of all studied indicators, particularly phosphorus.
• Rheumatoid arthritis (RA) exhibits significant differences in calcium and phosphorus elimination compared to coxarthrosis and gonarthrosis.
• Corticosteroids increase hydroxyproline elimination; age-related changes in RA suggest osteoporosis, osteomalacia, or impaired calcium binding.

Impact:

• Provides insights into the bone symptomatology of various inflammatory joint diseases.
• Highlights age- and disease-specific alterations in bone metabolism.
• Suggests RA may present with a significant osteopathy syndrome at onset.
• Characterizes ankylosing spondylitis (ASp) by reduced hydroxyproline elimination and altered calcium metabolism.